The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Open accessAbstract
The spontaneous deamination of cytosine is a major source of transitions from C•G to T•A base pairs, which account for half of known pathogenic point mutations in humans. The ability to efficiently convert targeted A•T base pairs to G•C could therefore advance the study and treatment of genetic diseases. The deamination of adenine yields inosine, which is treated as guanine by polymerases, but no enzymes are known to deaminate adenine in DNA. Here we describe adenine base editors (ABEs) that mediate the conversion of A•T to G•C in genomic DNA. We evolved a transfer RNA adenosine deaminase to operate on DNA when fused to a catalytically impaired CRISPR-Cas9 mutant. Extensive directed evolution and protein engineering resulted in seventh-generation ABEs that convert targeted A•T base pairs efficiently to G•C (approximately 50% efficiency in human cells) with high product purity (typically at least 99.9%) and low rates of indels (typically no more than 0.1%). ABEs introduce point mutations more efficiently and cleanly, and with less off-target genome modification, than a current Cas9 nuclease-based method, and can install disease-correcting or disease-suppressing mutations in human cells. Together with previous base editors, ABEs enable the direct, programmable introduction of all four transition mutations without double-stranded DNA cleavage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using a seventh-generation evolved transfer RNA adenosine deaminase attached to dCas9, researchers demonstrated conversion of A*T base pairs to G*C base pairs in a targeted fashion at efficiencies of around 50% with few undesired mutations in human cells.”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Gaudelli et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenine base editor (ABE), first described in 2017, generally does not induce DSBs (<1%) and is therefore a favorable alternative to Cas9 for single and multiplex gene knockouts.12,14”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Yet, these mutations occur significantly more often in human disease than transversion mutations (62% transition vs 38% transversion29,63).”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CBE converts cytosine to thymine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“ABE catalyzes the editing from adenine to guanine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Base editors are one such tool, which couple Cas9 nickases with nucleotide deaminases to achieve single nucleotide conversion without introducing DSBs.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Next-generation CRISPR tools, such as base editors, use enzymes like cytidine or adenine deaminases fused to Cas9 to introduce single nucleotide variants (SNVs) without DSBs.12,13”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Fusing adenine deaminase (an evolved TadA heterodimer) to a nickase-Cas9 creates an adenine base editor (ABE) that mediates A > G base changes via an inosine intermediate29”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Consistent with the literature1, ABE6.3 resulted in the highest A>G base editing efficiency at position A9 (6.9 ± 2.0%,2 µg ABE6.3) (Supplementary Fig. 1) and editing efficiency was dependent of the ABE enzyme concentration.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Adenine BEs comprise an evolved Escherichia coli TadA (ecTadA*, a tRNA adenosine deaminase evolved to accept DNA substrate) and Cas9 nickase, and mediate A•T to G•C substitutions1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“The ABE editing window occupies positions ~4–9 with the 1st, 5’ nucleotide (nt) of the candidate sgRNA counted as position 1 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Point mutations are a frequent cause of genetic disease, with ~50% of disease point mutations being G:C>A:T 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Self-citationClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., et al. (2016) · Science · doi:10.1126/science.aaf8729 · Cited by 1,349
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M. (2016) · Nature · doi:10.1038/nature17664 · Cited by 951
Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion
Zong, Y., Wang, Y., Li, C., Zhang, R., Chen, K., Ran, Y., Qiu, J., Wang, D., & Gao, C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3811 · Cited by 896
Komor, A. C., Zhao, K. T., Packer, M. S., Gaudelli, N. M., Waterbury, A. L., Koblan, L. W., Kim, Y. B., Badran, A. H., & Liu, D. R. (2017) · Science Advances · doi:10.1126/sciadv.aao4774 · Cited by 783
Self-citationKim, Y. B., Komor, A. C., Levy, J. M., Packer, M. S., Zhao, K. T., & Liu, D. R. (2017) · Nature Biotechnology · doi:10.1038/nbt.3803 · Cited by 758
Self-citationA system for the continuous directed evolution of biomolecules
Esvelt, K. M., Carlson, J. C., & Liu, D. R. (2011) · Nature · doi:10.1038/nature09929 · Cited by 694
Self-citationUracil in DNA – occurrence, consequences and repair
Krokan, H. E., Drabløs, F., & Slupphaug, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205996 · Cited by 500
Cited by
Sorted by citations
Items 901–1,000 of 1,024
Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases
Yu, W., & Wu, Z. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.011 · Cited by 48
Current trends in gene recovery mediated by the CRISPR-Cas system
Jang, H., Song, B., Hwang, G., & Bae, S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0466-1 · Cited by 49
Evaluation of Engineered CRISPR-Cas-Mediated Systems for Site-Specific RNA Editing
Marina, R. J., Brannan, K. W., Dong, K. D., Yee, B. A., & Yeo, G. W.-M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108350 · Cited by 46
Carotenoid Biofortification of Crops in the CRISPR Era
Zheng, X., Kuijer, H. N. J., & Al‐Babili, S. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.12.003 · Cited by 46
Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing
Hanson, B., Wood, M. J. A., & Roberts, T. C. (2021) · RNA Biology · doi:10.1080/15476286.2021.1874161 · Cited by 49
Toward Gene Transfer Nanoparticles as Therapeutics
Kavanagh, E. W., & Green, J. J. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102145 · Cited by 47
Wang, M., Krueger, J. B., Gilkey, A. K., Stelljes, E. M., Kluesner, M. G., Pomeroy, E. J., Skeate, J. G., Slipek, N. J., Lahr, W. S., Claudio Vázquez, P. N., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009560 · Cited by 45
Tariq, A., Mushtaq, M., Yaqoob, H., Bhat, B. A., Zargar, S. M., Raza, A., Ali, S., Charagh, S., Mubarik, M. S., Zaman, Q. U., et al. (2023) · GM Crops & Food · doi:10.1080/21645698.2023.2219111 · Cited by 45
Genetically modified large animal models for investigating neurodegenerative diseases
Yang, W., Chen, X., Li, S., & Li, X.-J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00729-8 · Cited by 45
Using Gene Editing Approaches to Fine-Tune the Immune System
Pavlovic, K., Tristán‐Manzano, M., Maldonado‐Pérez, N., Cortijo-Gutierréz, M., Sánchez-Hernández, S., Justicia-Lirio, P., Carmona-Luque, M. D., Herrera, C., Martín, F., & Benabdellah, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570672 · Cited by 49
Scalable characterization of the PAM requirements of CRISPR–Cas enzymes using HT-PAMDA
Walton, R. T., Hsu, J. Y., Joung, J. K., & Kleinstiver, B. P. (2021) · Nature Protocols · doi:10.1038/s41596-020-00465-2 · Cited by 49
Efficient Correction of a Hypertrophic Cardiomyopathy Mutation by ABEmax-NG
Ma, S., Jiang, W., Liu, X., Lu, W., Qi, T., Wei, J., Wu, F., Chang, Y., Zhang, S., Song, Y., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.318674 · Cited by 45
Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art
Rhym, L. H., & Anderson, D. G. (2022) · Med · doi:10.1016/j.medj.2022.02.001 · Cited by 45
Zhou, S., Kalds, P., Luo, Q., Sun, K., Zhao, X., Gao, Y., Cai, B., Huang, S., Kou, Q., Petersen, B., et al. (2022) · BMC Genomics · doi:10.1186/s12864-022-08594-6 · Cited by 45
Base editing of organellar DNA with programmable deaminases
Kim, J., & Chen, J. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00663-2 · Cited by 45
An adenine base editor variant expands context compatibility
Xiao, Y., Wu, Y., & Tang, W. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01994-3 · Cited by 48
Liver‐directed gene therapy for inherited metabolic diseases
Baruteau, J., Brunetti‐Pierri, N., & Gissen, P. (2024) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12709 · Cited by 46
Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease
Gupta, A. O., Sharma, A., Frangoul, H., Kanter, J., Mapara, M. Y., Dalal, J. D., Alavi, A., Jaroscak, J., Ayala, E., DiPersio, J. F., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2504835 · Cited by 45
Improvements of TKC Technology Accelerate Isolation of Transgene-Free CRISPR/Cas9-Edited Rice Plants
He, Y., Min, Z., Lihao, W., Wu, J., Wang, Q., Wang, R., & Zhao, Y. (2019) · Rice Science · doi:10.1016/j.rsci.2018.11.001 · Cited by 46
Bridge Helix of Cas9 Modulates Target DNA Cleavage and Mismatch Tolerance
Babu, K., Amrani, N., Jiang, W., Yogesha, S. D., Nguyen, R., Qin, P. Z., & Rajan, R. (2019) · Biochemistry · doi:10.1021/acs.biochem.8b01241 · Cited by 47
Application of CRISPR/Cas9-mediated gene editing for the development of herbicide-resistant plants
Han, Y., & Kim, J. (2019) · Plant Biotechnology Reports · doi:10.1007/s11816-019-00575-8 · Cited by 45
Progress and Challenges in the Improvement of Ornamental Plants by Genome Editing
Ahn, C. H., Ramya, M., An, H. R., Park, P. M., Kim, Y.-J., Lee, S. Y., & Jang, S. (2020) · Plants · doi:10.3390/plants9060687 · Cited by 45
Hoffmann, M. D., Mathony, J., zu Belzen, J. U., Harteveld, Z., Aschenbrenner, S., Stengl, C., Grimm, D., Correia, B. E., Eils, R., & Niopek, D. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1198 · Cited by 45
Prime Editing Guide RNA Design Automation Using PINE-CONE
Standage-Beier, K., Tekel, S. J., Brafman, D. A., & Wang, X. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00445 · Cited by 47
CRISPR/Cas9-Mediated Gene Editing Revolutionizes the Improvement of Horticulture Food Crops
Wang, T., Zhang, C., Zhang, H., & Zhu, H. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00104 · Cited by 45
Directed Evolution Methods for Enzyme Engineering
Nirantar, S. (2021) · Molecules · doi:10.3390/molecules26185599 · Cited by 48
CRISPR‐BETS: a base‐editing design tool for generating stop codons
Wu, Y., He, Y., Sretenovic, S., Liu, S., Cheng, Y., Han, Y., Liu, G., Bao, Y., Fang, Q., Zheng, X., et al. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13732 · Cited by 45
Cytokinins: A Genetic Target for Increasing Yield Potential in the CRISPR Era
Mandal, S., Ghorai, M., Anand, U., Roy, D., Kant, N., Mishra, T., Mane, A. B., Jha, N. K., Lal, M. K., Tiwari, R. K., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.883930 · Cited by 48
RetractedTrapping of CDC42 C-terminal variants in the Golgi drives pyrin inflammasome hyperactivation
Nishitani‐Isa, M., Mukai, K., Honda, Y., Nihira, H., Tanaka, T., Shibata, H., Kodama, K., Hiejima, E., Izawa, K., Kawasaki, Y., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211889 · Cited by 45
Adeno-Associated Virus (AAV) - Based Gene Therapies for Retinal Diseases: Where are We?
Ail, D., Malki, H., Zin, E. A., & Dalkara, D. (2023) · The Application of Clinical Genetics · doi:10.2147/tacg.s383453 · Cited by 40
Li, G., Jin, M., Li, Z., Xiao, Q., Lin, J., Yang, D., Liu, Y., Wang, X., Xie, L., Ying, W., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162809 · Cited by 44
Precise Genome Editing in Poultry and Its Application to Industries
Park, J. S., Lee, K. Y., & Han, J. Y. (2020) · Genes · doi:10.3390/genes11101182 · Cited by 46
Controllable genome editing with split-engineered base editors
Berríos, K. N., Evitt, N. H., DeWeerd, R. A., Ren, D., Luo, M., Barka, A., Wang, T., Bartman, C., Lan, Y., Green, A. M., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00880-w · Cited by 44
TAPE-seq is a cell-based method for predicting genome-wide off-target effects of prime editor
Kwon, J., Kim, M., Bae, S.-M., Jo, A., Kim, Y.-H., & Lee, J. K. (2022) · Nature Communications · doi:10.1038/s41467-022-35743-y · Cited by 45
Mengiste, A. A., Wilson, R. H., Weissman, R. F., Papa, L. J., Hendel, S. J., Moore, C. L., Butty, V. L., & Shoulders, M. D. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad003 · Cited by 46
Mechanisms regulating the CRISPR-Cas systems
Zakrzewska, M., & Burmistrz, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1060337 · Cited by 47
Genetic tools for metabolic engineering of Pichia pastoris
Wu, X., Cai, P., Yao, L., & Zhou, Y. J. (2023) · Engineering Microbiology · doi:10.1016/j.engmic.2023.100094 · Cited by 44
In Vivo Base Editing of Scn5a Rescues Type 3 Long QT Syndrome in Mice
Qi, M., Ma, S., Liu, J., Liu, X., Wei, J., Lu, W., Zhang, S., Chang, Y., Zhang, Y., Zhong, K., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065624 · Cited by 46
C-to-G editing generates double-strand breaks causing deletion, transversion and translocation
Huang, M. E., Qin, Y., Shang, Y., Hao, Q., Zhan, C., Lian, C., Luo, S., Liu, L. D., Zhang, S., Zhang, Y., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-023-01342-2 · Cited by 45
Programmable RNA base editing via targeted modifications
Song, J., Zhuang, Y., & Yi, C. (2024) · Nature Chemical Biology · doi:10.1038/s41589-023-01531-y · Cited by 44
Bradbury, A., Clapp, O., Biacsi, A.-S., Kuo, P. C., Gaju, O., Hayta, Ş., Zhu, J., & Lambing, C. (2025) · Plant Communications · doi:10.1016/j.xplc.2025.101386 · Cited by 44
CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors
Lee, C., Jo, D. H., Hwang, G., Yu, J., Kim, J., Park, S.-E., Kim, J., Kim, J. H., & Bae, S. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.05.013 · Cited by 47
Efficient Cas9-based genome editing of Rhodobacter sphaeroides for metabolic engineering
Mougiakos, I., Orsi, E., Ghiffary, M. R., Post, W. B., Maria, A. D., Adiego-Pérez, B., Kengen, S. W. M., Weusthuis, R. A., & John van der, O. O. S. T. (2019) · Microbial Cell Factories · doi:10.1186/s12934-019-1255-1 · Cited by 44
Base editing-mediated splicing correction therapy for spinal muscular atrophy
Lin, X., Chen, H., Lu, Y., Hong, S., Hu, X., Gao, Y., Lai, L., Li, J.-J., Wang, Z., Ying, W., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0304-y · Cited by 44
Exploiting CRISPR Cas9 in Three-Dimensional Stem Cell Cultures to Model Disease
Gopal, S., Rodrigues, A. L., & Dordick, J. S. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00692 · Cited by 46
Rosello, M., Vougny, J., Czarny, F., Mione, M., Concordet, J., Albadri, S., & Bene, F. D. (2021) · eLife · doi:10.7554/elife.65552 · Cited by 44
Efficient Peptide-Mediated In Vitro Delivery of Cas9 RNP
Gustafsson, O., Rädler, J., Roudi, S., Lehto, T., Hällbrink, M., Lehto, T., Gupta, D., Andaloussi, S. E., & Nordin, J. Z. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060878 · Cited by 44
Gene therapy for Fabry disease: Progress, challenges, and outlooks on gene-editing
Domm, J. M., Wootton, S. K., Medin, J. A., & West, M. L. (2021) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.07.006 · Cited by 45
CRISPR/Cas Genome Editing in Potato: Current Status and Future Perspectives
Tiwari, J. K., Buckseth, T., Challam, C., Zinta, R., Bhatia, N., Dalamu, D., Naik, S., Poonia, A. K., Singh, R. K., Luthra, S. K., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.827808 · Cited by 44
Base Editors for Citrus Gene Editing
Huang, X., Wang, Y., & Wang, N. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.852867 · Cited by 44
FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
Cui, Z., Tian, R., Huang, Z., Jin, Z., Li, L., Liu, J., Huang, Z., Xie, H., Liu, D., Mo, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29089-8 · Cited by 46
Self-citationBacterial Retrons Enable Precise Gene Editing in Human Cells
Zhao, B., Chen, S.-A. A., Lee, J., & Fraser, H. B. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0065 · Cited by 44
Disease modeling by efficient genome editing using a near PAM-less base editor in vivo
Rosello, M., Serafini, M., Mignani, L., Finazzi, D., Giovannangeli, C., Mione, M., Concordet, J., & Bene, F. D. (2022) · Nature Communications · doi:10.1038/s41467-022-31172-z · Cited by 46
Pattharaprachayakul, N., Lee, M., Incharoensakdi, A., & Woo, H. M. (2020) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2020.109619 · Cited by 43
Emerging applications of gene editing technologies for the development of climate-resilient crops
Chavhan, R. L., Jaybhaye, S. G., Hinge, V. R., Deshmukh, A. S., Shaikh, U. S., Jadhav, P. K., Kadam, U. S., & Hong, J. C. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1524767 · Cited by 55
Development of a base editor for protein evolution via in situ mutation in vivo
Hao, W., Cui, W., Cheng, Z., Han, L., Suo, F., Liu, Z., Zhou, L., & Zhou, Z. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab673 · Cited by 43
Off-target effects of base editors: what we know and how we can reduce it
Slesarenko, Y. S., Лавров, А. В., & Smirnikhina, S. (2021) · Current Genetics · doi:10.1007/s00294-021-01211-1 · Cited by 45
Applications of In Vitro Tissue Culture Technologies in Breeding and Genetic Improvement of Wheat
Yapa, A. W., Ramtekey, V., Ranawaka, B., & Basnet, B. R. (2022) · Plants · doi:10.3390/plants11172273 · Cited by 46
Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing
Onuma, H., Sato, Y., & Harashima, H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.02.008 · Cited by 47
CRISPR-Cas System: The Current and Emerging Translational Landscape
Bhokisham, N., Laudermilch, E., Traeger, L. L., Bonilla, T. D., Ruíz-Estévez, M., & Becker, J. R. (2023) · Cells · doi:10.3390/cells12081103 · Cited by 46
Engineered mRNA Delivery Systems for Biomedical Applications
Wang, J., Zhu, H., Gan, J., Liang, G., Li, L., & Zhao, Y. (2023) · Advanced Materials · doi:10.1002/adma.202308029 · Cited by 46
CRISPR-Cas9 base editing of pathogenic CaMKIIδ improves cardiac function in a humanized mouse model
Lebek, S., Caravia, X. M., Straub, L. G., Alzhanov, D., Tan, W. H., Li, H. Z., McAnally, J., Chen, K., Xu, L., Scherer, P. E., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci175164 · Cited by 46
Firdaus, Z., & Li, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042320 · Cited by 46
Advancing cancer research through organoid technology
Zeng, G., Yu, Y., Wang, M., Liu, J., He, G., Yu, S., Yan, H., Yang, L., Li, H., & Peng, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05824-1 · Cited by 43
Haider, S., & Mussolino, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094067 · Cited by 45
Mahat, D. B., Kumra, H., Castro, S. A., Metcalf, E., Nguyen, K. B., Morisue, R., Ho, W. W., Chen, I. X., Sullivan, B., Yim, L., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.06.005 · Cited by 44
Personalised genome editing – The future for corneal dystrophies
Moore, T., Christie, K. A., Marshall, J., & Nesbit, M. A. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.01.004 · Cited by 44
Inheritance of co-edited genes by CRISPR-based targeted nucleotide substitutions in rice
Shimatani, Z., Fujikura, U., Ishii, H., Matsui, Y., Suzuki, M., Ueke, Y., Taoka, K.-I., Terada, R., Nishida, K., & Kondo, A. (2018) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2018.04.028 · Cited by 44
Bron, P. A., Marcelli, B., Mulder, J., van der Els, S., Morawska, L. P., Kuipers, O. P., Kok, J., & Kleerebezem, M. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.09.004 · Cited by 43
Mokalled, M. H., & Poss, K. D. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.10.015 · Cited by 44
Genome editing of potato using CRISPR technologies: current development and future prospective
Dangol, S. D., Barakate, A., Stephens, J., Çalışkan, M. E., & Bakhsh, A. (2019) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-019-01662-y · Cited by 43
State-of-the-Art 2019 on Gene Therapy for Phenylketonuria
Grisch‐Chan, H. M., Schwank, G., Harding, C. O., & Thöny, B. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.111 · Cited by 45
Genome Editing for Mucopolysaccharidoses
Poletto, É., Baldo, G., & Gomez‐Ospina, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020500 · Cited by 45
Advances in genome editing for genetic hearing loss
Ding, N., Lee, S., Lieber-Kotz, M., Yang, J., & Gao, X. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.001 · Cited by 43
An overview of development in gene therapeutics in China
Wang, D., Wang, K., & Cai, Y. (2020) · Gene Therapy · doi:10.1038/s41434-020-0163-7 · Cited by 45
Qi, T., Wu, F., Xie, Y., Gao, S., Li, M., Pu, J., Li, D., Lan, F., & Wang, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590581 · Cited by 45
Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide
Liu, Z., Chen, S., Jia, Y., Shan, H., Chen, M., Song, Y., Lai, L., & Li, Z. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1775-2 · Cited by 35
Aulicino, F., Pelosse, M., Toelzer, C., Capin, J., Ilegems, E., Meysami, P., Rollarson, R., Berggren, P., Dillingham, M. S., Schaffitzel, C., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac587 · Cited by 43
Kulcsár, P. I., Tálas, A., Ligeti, Z., Krausz, S. L., & Welker, E. (2022) · Nature Communications · doi:10.1038/s41467-022-34527-8 · Cited by 46
Wang, P., Xu, L. M., Gao, Y., & Han, R. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.04.009 · Cited by 42
Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
Chasov, V. V., Mirgayazova, R., Zmievskaya, E., Khadiullina, R., Valiullina, A., Clarke, J. R. S., Rizvanov, A. A., Baud, M. G. J., & Bulatov, E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01460 · Cited by 42
Enhancing Prime Editing Efficiency and Flexibility with Tethered and Split pegRNAs
Feng, Y., Liu, S., Mo, Q., Xiao, X., Liu, P., & Ma, H. (2022) · Protein & Cell · doi:10.1093/procel/pwac014 · Cited by 42
Gene Therapy and Gene Editing for β-Thalassemia
Christakopoulos, G. E., Telange, R., Yen, J. S., & Weiss, M. J. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.012 · Cited by 43
Zhang, C., Zhong, X., Li, S., Yan, L., Li, J., He, Y., Lin, Y., Zhang, Y., & Xia, L. (2023) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13543 · Cited by 42
Prediction of base editor off-targets by deep learning
Zhang, C., Yang, Y., Qi, T., Zhang, Y., Hou, L., Wei, J., Yang, J., Shi, L. M., Ong, S., Wang, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41004-3 · Cited by 44
Prime editing in plants: prospects and challenges
Vats, S., Kumar, J., Sonah, H., Zhang, F., & Deshmukh, R. K. (2024) · Journal of Experimental Botany · doi:10.1093/jxb/erae053 · Cited by 42
Alariqi, M., Ramadan, M., Yu, L., Hui, F., Hussain, A., Zhou, X., Yu, Y., Zhang, X., & Jin, S. (2025) · Advanced Science · doi:10.1002/advs.202416331 · Cited by 42
New tools for old drugs: Functional genetic screens to optimize current chemotherapy
Gerhards, N. M., & Rottenberg, S. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.01.001 · Cited by 43
CRISPR RNA-guided autonomous delivery of Cas9
Wilkinson, R. A., Martin, C. D., Nemudryi, A. A., & Wiedenheft, B. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0173-y · Cited by 43
Koeppel, I., Hertig, C. W., Hoffie, R. E., & Kumlehn, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112647 · Cited by 46
Krooss, S. A., Dai, Z., Schmidt, F., Rovai, A., Fakhiri, J., Dhingra, A., Yuan, Q., Yang, T., Balakrishnan, A., Steinbrück, L., et al. (2019) · iScience · doi:10.1016/j.isci.2019.100764 · Cited by 42
GOTI, a method to identify genome-wide off-target effects of genome editing in mouse embryos
Zuo, E., Sun, Y., Wu, W., Yuan, T., Ying, W., Sun, H., Yuan, L., Steinmetz, L. M., Li, Y., & Yang, H. (2020) · Nature Protocols · doi:10.1038/s41596-020-0361-1 · Cited by 43
The Roles of TGF-β Signaling in Cerebrovascular Diseases
Zhang, Y., & Yang, X. Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.567682 · Cited by 45
Universal toxin-based selection for precise genome engineering in human cells
Li, S., Akrap, N., Cerboni, S., Porritt, M. J., Wimberger, S., Lundin, A., Möller, C., Firth, M. A., Gordon, E., Lazovic, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20810-z · Cited by 46
Bioorthogonally Activatable Base Editing for On-Demand Pyroptosis
Ngai, W. S. C., Yang, S., Zeng, X., Liu, Y., Lin, F., Wang, X., Zhang, H., Fan, X., & Chen, P. R. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c12924 · Cited by 42
Bodai, Z., Bishop, A. L., Gantz, V. M., & Komor, A. C. (2022) · Nature Communications · doi:10.1038/s41467-022-29989-9 · Cited by 44
Self-citationPetri, K., Kim, D. Y., Sasaki, K. E., Canver, M. C., Wang, X., Shah, H., Lee, H., Horng, J. E., Clement, K., Iyer, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.05.438458 · Cited by 44
Self-citationPaving the way towards precise and safe CRISPR genome editing
Śledziński, P., Dabrowska, M., Nowaczyk, M., & Olejniczak, M. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107737 · Cited by 43
Wolff, J. H., & Mikkelsen, J. G. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00865-4 · Cited by 47
Current advances in gene therapy of mitochondrial diseases
Soldatov, V. O., Kubekina, M. V., Skorkina, M. Y., Белых, А. Е., Egorova, T. V., Корокин, М. В., Pokrovskiy, M. V., Deykin, A. V., & Angelova, P. R. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03685-0 · Cited by 45
Metadata
- Authors
- Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Liu, David R.
- ORCID
- Venue
- Nature
- Published
- 2017-11-01
- Volume
- 551
- Issue
- 7681
- Pages
- 464-471
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5726555
- OpenAlex
- W2766599608
- Cited by
- 4,184
- References
- 46
- Citations by year
- 2026: 460 · 2025: 501 · 2024: 521 · 2023: 599 · 2022: 557 · 2021: 489 · 2020: 474 · 2019: 332 · 2018: 237 · 2017: 8
- FWCI
- 117.56
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-05-02)
- Open access
- green
- europepmc.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Human Genome Research Institute (RM1HG009490)
- National Institute of General Medical Sciences (T32GM008313, F32GM106621, R35GM118062, F32GM112366)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- adenine base editors, base editing, cytosine deamination, CRISPR/Cas9, directed evolution, protein engineering, transition mutations, point mutations, single nucleotide polymorphisms
- MeSH terms
- Gene Editing, Adenosine Deaminase, DNA, Humans, Models, Molecular, Genome, Human, Base Pairing, Polymorphism, Single Nucleotide, Cell Line, Tumor, DNA Cleavage, HEK293 Cells, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
